TubeX to Showcase Advanced Nephrostomy Tube Fixation at WHX Miami 2026
TubeX to Showcase Advanced Nephrostomy Tube Fixation at WHX Miami 2026
The company will Introduce to the North American market, Nephro-Safe, a next-generation solution for secure and stable nephrostomy care.
Miami, FL, 2026, June 1, 2026 – TubeX, a developer of advanced drainage tube securement solutions, will present innovative Nephro-Safe securement device, at World Health Expo (WHX) 2026, taking place June 17-19, 2026, in Miami, Florida.
Nephro-Safe is a next-generation nephrostomy tube stabilizer designed to address persistent challenges in nephrostomy care, including dislodgement, patient discomfort, and complication-related costs. TubeX will showcase Nephro-Safe at Pod Y106 in the Future X zone.
As procedure volumes continue to grow across U.S. healthcare systems, providers are increasingly looking for reliable, easy-to-use solutions that support both clinical outcomes and operational efficiency.
TubeX’s participation at WHX 2026 marks its strategic entry into the North American market, with a clear focus on building strong distribution partnerships. Nephro-Safe has been developed to align with the high standards of U.S. healthcare while offering a differentiated product that is simple to position and scale.
The device features a dual-layer system designed to enhance both stability and patient comfort:
- Secure Anchoring – A high-performance adhesive platform, with optional suturing capability, ensures consistent and reliable fixation.
- Movement Absorption – A protective structure reduces the transfer of external forces to the insertion site, helping minimize trauma, irritation, and accidental dislodgement.
These features support consistent performance across hospital and home care settings, helping reduce avoidable complications and unplanned interventions, a key value driver for providers and payers alike.
“The nephrostomy segment continues to present clear gaps in reliable tube stabilization, especially as more care shifts beyond the hospital,” said Tal Hadass, CMO at TubeX. “For U.S. distributors, this represents a strong commercial opportunity. Nephro-Safe offers a differentiated solution that is easy to integrate into existing portfolios, addresses well-known clinical challenges, and responds directly to the growing demand for safer, more cost-effective nephrostomy management.”
With a rising number of nephrostomy procedures performed annually in the United States, the demand for effective securement solutions continues to expand. TubeX is actively seeking distribution partners interested in bringing an innovative, high-value product to market.